// App-Quantinova.ai

13846 2014 AHA : The Relationship of Platelet Function Measurements with Bleeding Outcomes During Long-term Treatment with Dual Antiplatelet Therapy in Medically Managed NSTE-ACS Patients

Researchers

Presenter

  • E. Magnus Ohman

Principal Investigators

  • Benjamin Neely

  • Paul A. Gurbel

  • Matthew T. Roe

  • Joseph A. Jakubowski

  • Deepak L. Bhatt

  • Harvey D. White

  • Diego Ardissino

  • Keith A. Fox

  • Dorairaj Prabhakaran

  • Paul W. Armstrong

  • David Erlinge

Medical Centers

  • The University of Edinburgh, Edinburgh, United Kingdom

  • Duke Clinical Research Institute, Durham, NC

  • Univ. of Alberta, Edmonton, Alberta, Canada.

  • Sinai Hospital of Baltimore, Baltimore, MD

  • Lund Univ., Lund, Sweden.

  • Univ of Parma, Parma, Italy

  • Medical Center Alkmaar, Alkmaar, Netherlands

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • Centre for Chronic Disease Control, New Delhi, India

  • Auckland City Hospital, Auckland, New Zealand

Locations

  • Canada

  • Italy

  • Netherlands

  • United Kingdom

  • United States

  • India

  • Sweden

  • New Zealand

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Gastrointestinal bleeding

  • Acute Coronary Syndromes

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Prasugrel

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim